Fig. 1
Pathologic complete response (pCR) rate according to neoadjuvant treatment regimens (A) in all patients and (B) patients with available stromal tumor-infiltrating lymphocytes (sTILs) data
Fig. 1 | Breast Cancer Research
Pathologic complete response (pCR) rate according to neoadjuvant treatment regimens (A) in all patients and (B) patients with available stromal tumor-infiltrating lymphocytes (sTILs) data